ISO 10993 is the international cornerstone standard for biological evaluation of medical devices. The 2025 edition (6th edition) represents a major restructuring to align completely with ISO 14971 risk management principles. This standard applies to any medical device that comes into direct or indirect contact with the human body, including medical textiles such as wound dressings, surgical gowns, and medical wearables [1].
The biocompatibility evaluation under ISO 10993 considers both the first use of the finished device and changes throughout its lifecycle. The four primary goals are: (1) ensuring non-toxic materials that don't release harmful substances, (2) achieving biocompatibility where materials interact with human tissues without adverse reactions, (3) minimizing patient discomfort, and (4) meeting FDA/EMA regulatory requirements for market access [4].
ISO 10993-1:2018 (withdrawn 2025-11, replaced by 2025 edition) is the cornerstone standard for biological evaluation of medical devices. It defines principles and requirements for evaluating biocompatibility of medical devices to support demonstration of safety [1].
Important for Southeast Asia Apparel Exporters: ISO 10993 is specifically designed for medical devices, not conventional apparel. If you manufacture women's blouses, shirts, or fashion garments for general consumer use, ISO 10993 is likely not applicable to your products. However, if you produce medical textiles (wound dressings, surgical gowns, compression garments for medical use), ISO 10993 biocompatibility testing becomes a regulatory requirement for market access in the US (FDA 510(k)), EU (MDR), and other regulated markets [4].

